When managing asthma or chronic obstructive pulmonary disease (COPD), selecting the right inhaler can make a major impact on your daily life. Two commonly suggested options are Advair and Symbicort. Both medicines can help regulate breathing symptoms and avoid flare-ups, but understanding key differences may make one better for you.
Both Advair and Symbicort are combination maintenance inhalers for asthma, meaning they consist of two medicines that function together. The first type is an inhaled corticosteroid (ICS), where swelling and inflammation get reduced in the airways. The other is a long-acting bronchodilator (LABA), which gives a relaxation effect to the muscles around the airways, making breathing comparatively easier.
Advair consists of salmeterol (the bronchodilator) and fluticasone (the steroid). Symbicort contains formoterol (the bronchodilator) and budesonide (the steroid). While the specific drugs are different in composition, they work similarly to regulate symptoms and enhance breathing over a period. When comparing Advair vs. Symbicort, it is crucial to understand their differences in detail. So, moving ahead, in this blog, we will learn about the key differences between Advair and Symbicort.

The delivery mechanism of these two drugs is taken into consideration as a major difference. Generic Advair is available in two types: a dry powder inhaler (Diskus) and a metered-dose inhaler (HFA). Symbicort is used only through a metered-dose inhaler.
Dry powder inhalers are inhaled through a long breath, which allows the medicine to go straight into your lungs. Some people find this easier because they don’t need to coordinate their breathing while pressing the inhaler. However, it requires sufficient lung strength to work effectively.
A metered-dose inhaler discharges a medicine spray. You are required to press the inhaler while you gently breathe in deeply. Some form of coordination is required, but using a spacer device can make it easier for you to ensure the maximum dose reaches your lungs. The suitable option relies on your comfort, coordination, and breathing ability. Your healthcare provider can allow you to practice proper technique.
While exploring Symbicort vs. Advair, it is important to note that dosing can differ by inhaler type. Some generic Advair forms require one inhalation per dose, while others, along with generic Symbicort, require two puffs per dose. You usually use both medicines twice a day, about 12 hours apart. Follow your prescribed dosing exactly. Taking too little a dose may not regulate your symptoms, while taking too much can increase the risk of side effects. It is better to take your doses at the same time each day to keep your symptoms under control.
Age approvals vary between these medications. Generic Symbicort is authorized for children 6 years old and below for asthma. Advair Diskus can be used in children 4 years old and below, while Advair HFA is mainly authorized for patients 12 years and older. For COPD, both medicines are normally used only in adults. In children, use of the correct inhaler is a must. Most children benefit from using a spacer with aerosol inhalers to ensure the medicine reaches the lungs effectively. Therefore, healthcare providers should help children learn and practice proper technique.
Advair HFA is a metered-dose inhaler that releases an inhalation aerosol in strengths of 45/21 mcg, 230/21, and 115/21 mcg of fluticasone/salmeterol. Advair Diskus releases an inhalation powder in strengths of 100/50 mcg, 500/50 mcg, or 250/50 mcg of fluticasone/salmeterol. Symbicort is available as an inhalation aerosol in strengths of 160/4.5 mcg or 80/4.5 mcg of budesonide/formoterol. Below are the other factors of the three medications: Advair Diskus, Advair HFA, and Symbicort:
| Factor | Generic Advair Diskus | Generic Advair HFA | Generic Symbicort |
| Ingredients | Fluticasone propionate and salmeterol xinafoate | Fluticasone propionate and salmeterol xinafoate | Micronized budesonide (an inhaled corticosteroid) and micronized formoterol fumarate dihydrate (a long-acting beta2-agonist bronchodilator) |
| Device | Breath-activated dry powder inhaler device | Pressurized metered-dose inhaler (pMDI) | A dry powdered inhaler (DPI) and pressurized metered-dose inhaler (pMDI) |
| Dosing | 1 inhalation twice daily | 2 puffs twice per day | 2 inhalations (puffs) twice daily |
| Uses | To prevent asthma attacks and chronic obstructive pulmonary disease (COPD) | To prevent asthma attacks | Long-term maintenance and treatment of asthma attacks and COPD |
| Beginning of Efficacy | 15-30 minutes | 15-30 minutes | 15 minutes |
| Peak effect | 1-4 hours | 1-4 hours | 1-3 hours |
| Length of Time | 12 hours | 12 hours | 12 hours |
| Inhaler intensity | Moderate difficulty | Higher difficulty | Higher difficulty |
| Side effects | Black and tarry stools, blurred vision, blindness, chills, cough, decreased vision, difficulty with breathing or swallowing, eye pain, fast heartbeat, headache, and fever | Black and tarry stools, blurred vision, blindness, chills, cough, decreased vision, difficulty with breathing or swallowing, eye pain, fast heartbeat, headache, and fever | Upper respiratory tract infection (URTI), throat pain, headache, back pain, sinus infection, nasal congestion, vomiting, stomach discomfort, and oral thrush |
The effectiveness and efficiency of both Advair and Symbicort are sufficiently high to regulate the symptoms of asthma and COPD as per clinical studies. Comparisons show similar effectiveness in some cases, so the choice often comes down to individual patient factors rather than major differences in therapeutic results.
Some patients may prefer responding towards one medicine over another because of individual differences in inhaler technique, personal tolerance, or drug metabolism. This is why healthcare experts need to determine different medicines to identify the suitable treatment for each patient. The effectiveness of the medicine is dependent on proper inhaler technique and continuous daily use as prescribed.
It is possible to switch between Advair and Symbicort under the below-mentioned conditions. But before that, talk to your doctor, as they can provide extra information to help you decide the best course of action.
You would be more likely to get prescribed Advair (HFA or Diskus) under the following circumstances:
You have asthma and require a specific strength that compares to the Advair product.
Your healthcare provider prefers a dry-powder device like the Diskus, or you cannot use an HFA well.
Your insurance coverage includes generic fluticasone/salmeterol at a reasonable cost.
You would be more likely to get prescribed Symbicort if:
You have asthma, and your doctor gives you a treatment where Symbicort can also help with symptoms in specific situations.
You have COPD, and your healthcare provider gives you 160/45 strength or Aerosphere for maintenance.
Your insurance coverage includes budesonide/formoterol.
Although Advair and Symbicort are different, they are in the same drug class; your body tends to respond differently. Significantly, you do not start, stop, or switch any of your medication treatments on your own without your doctor’s suggestion.
So far, we have studied fluticasone salmeterol vs. budesonide formoterol in the blog above, where we learned that Advair Diskus (fluticasone/salmeterol) and Symbicort (budesonide/formoterol) are combination inhalers that are FDA-authorized for asthma and COPD. Advair HFA is only approved for asthma. On the other hand, Symbicort may be a preferred choice for asthma, but they’re equally effective when it comes to COPD. Advair and Symbicort have similar side effects, but the risk of pneumonia might be comparatively higher with Advair in patients with COPD.
Whether you take Advair or Symbicort, complying with your day-to-day regimen will help you get the most benefit from your treatment. In short, these three drugs combine an inhaled corticosteroid to help lower lung inflammation and an inhaled bronchodilator to help relax the muscles around your airways and ease your breathing.
Advair contains fluticasone and salmeterol, whereas Symbicort contains budesonide and formoterol. Symbicort treats asthma in patients 6 years of age and older, whereas Advair treats asthma in patients 4 years and older. The typical dosage of Symbicort is two inhalations twice daily, while the typical dosage of Advair is one inhalation twice daily.
Symbicort is sometimes preferred over Advair because it can double as a rescue inhaler, giving you quick relief when needed. Some studies suggest Symbicort is more effective for asthma, but other studies using real-world data find Advair and Symbicort similarly effective. So, whichever inhaler you use, follow your healthcare provider’s instructions every day.
Yes, Advair and Symbicort are commonly used as approved medications for daily maintenance treatment for chronic obstructive pulmonary disease (COPD).
Yes, both Advair and Symbicort are meant to be used as long-term maintenance medications on a daily basis for preventing asthma and COPD symptoms.
Yes, both Advair and Symbicort contain an inhaled corticosteroid and a long-acting bronchodilator. Both drugs have similar safety profiles. Because the medicines go straight to the lungs, they may cause fewer whole-body side effects than steroid pills, especially when used at the lowest effective dose.
Content published on DayNightDrugs is created and reviewed in line with medically responsible editorial standards. Please read our Editorial Content Policy to learn how we ensure accuracy, transparency, and high-quality health information.
Processing currency - All transactions are processed in US Dollars
Copyright ©2008-2026
All Rights Reserved
Comments